Office of the Director, National Institutes of Health; Notice of Meeting, 28235-28236 [2013-11352]

Download as PDF Federal Register / Vol. 78, No. 93 / Tuesday, May 14, 2013 / Notices Cancer Control, National Institutes of Health, HHS) Dated: May 7, 2013. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–11347 Filed 5–13–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings mstockstill on DSK4VPTVN1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel, Novel Imaging Agents to Expand the Clinical Toolkit for Cancer Diagnosis, Staging, and Treatment. Date: May 29, 2013. Time: 12:00 p.m. to 2:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Cancer Institute, 9609 Medical Center Drive, Room 4W034, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Sonya Roberson, Ph.D., Health Scientist Administrator, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W116, Bethesda, MD 20892–8328, 240–276– 6347, robersos@mail.nih.gov. This notice is being published less than 15 days prior to the meeting date due to scheduling conflicts. Name of Committee: National Cancer Institute Special Emphasis Panel, Cancer Theranostics II. Date: June 3, 2013. Time: 11:00 a.m. to 3:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 9609 Medical Center Drive, Room 7W030, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Savvas C Makrides, Ph.D., Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural VerDate Mar<15>2010 16:52 May 13, 2013 Jkt 229001 Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W246, Bethesda, MD 20892–8328, 240–276–6374, makridessc@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Companion Diagnostics—Phase II. Date: June 5, 2013. Time: 10:00 a.m. to 2:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 9609 Medical Center Drive, Room 7W032, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Adriana Stoica, Ph.D., Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W234, Bethesda, MD 20892–8328, 240–276–6368, Stoicaa2@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Pharmacodynamic Assays TX2 of 2. Date: June 6, 2013. Time: 1:00 p.m. to 3:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Cancer Institute, 9609 Medical Center Drive, Room 7W034, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Thomas M Vollberg, Ph.D., Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W102, Bethesda, MD 20892–8328, 240–276–6341, vollbert@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Biosensors for Early Cancer Detection and Risk Assessment. Date: June 10, 2013. Time: 11:00 a.m. to 1:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 9609 Medical Center Drive, Room 6W032, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Kenneth L. Bielat, Ph.D., Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W244, Bethesda, MD 20892–8329, 240–276–6373, bielatk@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Radioprotector/Mitigator Development to Decrease Normal Tissue Injury During Radiotherapy. Date: June 13, 2013. Time: 12:00 p.m. to 3:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W302, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Viatcheslav A Soldatenkov, MD, Ph.D., Scientific Review Officer, Special Review and Logistics Branch, PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 28235 Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W254, Bethesda, MD 20892– 8329, 240–276–6378, soldatenkovv@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Development of a Molecular Diagnostic Assay to Detect Basal-like Breast Cancer. Date: June 13, 2013. Time: 12:00 p.m. to 1:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 9609 Medical Center Drive, Room 6W032, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Sonya Roberson, Ph.D., Health Scientist Administrator, Resources and Training Review Branch, Division Of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W116, Bethesda, MD 20892–8328, 240–276–6347, robersos@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Process Analytic Technologies (PAT) for Biologics: Innovative Methods for Monitoring and Analyzing Product Quality. Date: June 19, 2013. Time: 9:00 a.m. to 1:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 9609 Medical Center Drive, Room 2W034, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Thomas A. Winters, Ph.D., Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W268, Bethesda, MD 20892–8328, 240–276–6386, twinters@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: May 7, 2013. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–11345 Filed 5–13–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director, National Institutes of Health; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the E:\FR\FM\14MYN1.SGM 14MYN1 28236 Federal Register / Vol. 78, No. 93 / Tuesday, May 14, 2013 / Notices Advisory Committee to the Director, National Institutes of Health. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended because the premature disclosure of program documents—PAC and the discussions would likely to significantly frustrate implementation of recommendations. license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: https:// acd.od.nih.gov, where an agenda and any additional information for the meeting will be posted when available. Dated: May 8, 2013. Anna Snouffer, Deputy Director, Office of Federal Advisory Committee Policy. [FR Doc. 2013–11352 Filed 5–13–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health mstockstill on DSK4VPTVN1PROD with NOTICES Name of Committee: Advisory Committee to the Director, National Institutes of Health. Date: June 13–14, 2013. Open: June 13, 2013, 9:00 a.m. to 12:00 p.m. Agenda: NIH Director’s Report. Place: National Institutes of Health, Building 31, 6th Floor, Conference Room 6C6, 31 Center Drive, Bethesda, MD 20892. Closed: June 13, 2013, 1:00 p.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Building 31, 6th Floor, Conference Room 6C6, 31 Center Drive, Bethesda, MD 20892. Open: June 13, 2013, 2:00 p.m. to 5:00 p.m. Agenda: Updates and discussions on other committee business. Place: National Institutes of Health, Building 31, 6th Floor, Conference Room 6C6, 31 Center Drive, Bethesda, MD 20892. Open: June 14, 2013, 9:00 a.m. to 1:00 p.m. Agenda: ACD Biomedical Workforce Working Group report. Place: National Institutes of Health, Building 31, 6th Floor, Conference Room 6C6, 31 Center Drive, Bethesda, MD 20892. Contact Person: Gretchen Wood, Staff Assistant, National Institutes of Health, Office of the Director, One Center Drive, Building 1, Room 103, Bethesda, MD 20892, 301–496–4272, woodgs@od.nih.gov. National Cancer Institute Amended; Notice of Meeting Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s National Institute on Deafness and Other Communication Disorders; Notice of Closed Meetings VerDate Mar<15>2010 16:52 May 13, 2013 Jkt 229001 Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, May 23, 2013, 11:30 a.m. to May 23, 2013, 03:30 p.m., National Cancer Institute— Shady Grove, 9609 Medical Center Drive, Room 7W032, Rockville, MD 20850 which was published in the Federal Register on May 03, 2013, 78FR26056. This notice is being amended due to a change in the meeting date and time from 11:30 a.m. to 3:30 p.m. on May 23, 2013 to 12:00 p.m. to 3:00 p.m. on May 22, 2013. The meeting is closed to the public. Dated: May 7, 2013. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–11349 Filed 5–13–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Deafness and Other Communication Disorders Special Emphasis Panel, CS Translational. Date: June 4, 2013. Time: 12:00 p.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6120 Executive Blvd, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Sheo Singh, Ph.D., Scientific Review Officer, Scientific Review Branch, Division of Extramural Activities, Executive Plaza South, Room 400C, 6120 Executive Blvd., Bethesda, MD 20892, 301– 496–8683, singhs@nidcd.nih.gov. Name of Committee: National Institute on Deafness and Other Communication Disorders Special Emphasis Panel, Chemosensory Fellowship Application Review. Date: June 11, 2013. Time: 11:00 a.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6120 Executive Blvd., Rockville, MD 20852, (Telephone Conference Call). Contact Person: Shiguang Yang, DVM, Ph.D., Scientific Review Officer, Division of Extramural Activities, NIDCD, NIH, 6120 Executive Blvd., Bethesda, MD 20892, 301– 496–8683. Name of Committee: National Institute on Deafness and Other Communication Disorders Special Emphasis Panel, HB Fellowship Applications Review. Date: June 12, 2013. Time: 11:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6120 Executive Blvd., Rockville, MD 20852, (Telephone Conference Call). Contact Person: Sheo Singh, Ph.D., Scientific Review Officer, Scientific Review Branch, Division of Extramural Activities, Executive Plaza South, Room 400C, 6120 Executive Blvd., Bethesda, MD 20892, 301– 496–8683, singhs@nidcd.nih.gov. Name of Committee: Communication Disorders Review Committee. Date: June 13–14, 2013. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road NW., Washington, DC 20015. Contact Person: Andrea B. Kelly, Ph.D., Scientific Review Officer, Division of Extramural Activities, Scientific Review Branch, NIDCD, NIH, 6120 Executive Blvd., Ste 400C, MSC 7180, Rockville, MD 20892, (301) 496–8683, kellya2@nidcd.nih.gov. Name of Committee: National Institute on Deafness and Other Communication Disorders Special Emphasis Panel, NIDCD Clinical Trial and Translational Research Applications. E:\FR\FM\14MYN1.SGM 14MYN1

Agencies

[Federal Register Volume 78, Number 93 (Tuesday, May 14, 2013)]
[Notices]
[Pages 28235-28236]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-11352]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the

[[Page 28236]]

Advisory Committee to the Director, National Institutes of Health.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended because the premature disclosure of program 
documents--PAC and the discussions would likely to significantly 
frustrate implementation of recommendations.

    Name of Committee: Advisory Committee to the Director, National 
Institutes of Health.
    Date: June 13-14, 2013.
    Open: June 13, 2013, 9:00 a.m. to 12:00 p.m.
    Agenda: NIH Director's Report.
    Place: National Institutes of Health, Building 31, 6th Floor, 
Conference Room 6C6, 31 Center Drive, Bethesda, MD 20892.

    Closed: June 13, 2013, 1:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Building 31, 6th Floor, 
Conference Room 6C6, 31 Center Drive, Bethesda, MD 20892.

    Open: June 13, 2013, 2:00 p.m. to 5:00 p.m.
    Agenda: Updates and discussions on other committee business.
    Place: National Institutes of Health, Building 31, 6th Floor, 
Conference Room 6C6, 31 Center Drive, Bethesda, MD 20892.

    Open: June 14, 2013, 9:00 a.m. to 1:00 p.m.
    Agenda: ACD Biomedical Workforce Working Group report.
    Place: National Institutes of Health, Building 31, 6th Floor, 
Conference Room 6C6, 31 Center Drive, Bethesda, MD 20892.

    Contact Person: Gretchen Wood, Staff Assistant, National 
Institutes of Health, Office of the Director, One Center Drive, 
Building 1, Room 103, Bethesda, MD 20892, 301-496-4272, 
woodgs@od.nih.gov.

    Any interested person may file written comments with the committee 
by forwarding the statement to the Contact Person listed on this 
notice. The statement should include the name, address, telephone 
number and when applicable, the business or professional affiliation of 
the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one form 
of identification (for example, a government-issued photo ID, driver's 
license, or passport) and to state the purpose of their visit.
    Information is also available on the Institute's/Center's home 
page: https://acd.od.nih.gov, where an agenda and any additional 
information for the meeting will be posted when available.

    Dated: May 8, 2013.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-11352 Filed 5-13-13; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.